Monte Rosa Therapeutics, Inc.

GLUE • NASDAQ • Stock Fundamentals

Monte Rosa Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Markus Warmuth, with a market cap of $1.4B.

Market Cap$1.4B

Employees109.0

CEOMarkus Warmuth

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

View report

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Income Statement Balance Sheet Cash Flow Segments

Financials

Based on Q1 2026 filing

View all metrics

Monte Rosa Therapeutics, Inc. FAQ

Common questions about Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of $1.4B and trades on NASDAQ.

Monte Rosa Therapeutics, Inc. has approximately 109 employees.

Monte Rosa Therapeutics, Inc.

Financials

Monte Rosa Therapeutics, Inc. FAQ

What is Monte Rosa Therapeutics, Inc.'s market cap?

How many employees does Monte Rosa Therapeutics, Inc. have?